IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

New Leaf Venture Partners, L.L.C.

Q2 2023 Holdings

Filed 2023-08-10 | 14 holdings | $116.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arvinas Inc(ARVN)COM04335A105$32.0M1,289,52127.5%
Rallybio CorporationCOM75120L100$18.7M3,301,60316.0%
Dice Therapeutics IncCOM23345J104$17.3M371,69314.8%
Deciphera Pharmaceuticals Inc(DCPHEUR)COM24344T101$17.0M1,209,57114.6%
Edgewise Therapeutics Inc(EWTX)COM28036F105$12.0M1,553,66110.3%
Cogent Biosciences Inc.(COGT)COM19240Q201$5.9M501,5305.1%
Crinetics Pharmaceuticals Inc(CRNX)COM22663K107$2.5M141,0002.2%
Rocket Pharmaceuticals Inc(RCKT)COM77313F106$2.3M118,2422.0%
Passage BIOCOM702712100$2.3M2,497,9222.0%
Harpoon Therapeutics IncCOM41358P106$2.2M3,156,6991.9%
Alector Inc(ALEC)COM014442107$2.0M339,5691.8%
Aravive Inc(VSAREUR)COM03890D108$1.2M946,4231.0%
X4 Pharmaceuticals Inc(ASNSUSD)COM98420X103$649.9K335,0000.6%
Iterum Therapeutics PLCSHSG6333L200$103.9K97,0840.1%